• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hormones and mammographic breast density].

作者信息

Boisserie-Lacroix M, Lebiez-Michel N, Cavagni P, Bentolila J, Laumonier H, Bouzgarrou M, Trillaud H

机构信息

Service de Radiologie, CHU Saint-André, 1 rue Jean Burguet, 33075 Bordeaux cedex, France.

出版信息

J Radiol. 2008 Sep;89(9 Pt 2):1196-203. doi: 10.1016/s0221-0363(08)73930-1.

DOI:10.1016/s0221-0363(08)73930-1
PMID:18772804
Abstract

Breast constitutional density may be altered and increased (acquired density) by hormonal interventions such as hormone replacement therapy (HRT). The effects of endogenous (steroids, prolactin, insulin-like factors...) and exogenous (HRT, levonorgestrel IUD, tibolone, tamoxifen, SERMs) hormones will be reviewed. Continuous combined estrogen-progestin preparations are most likely to cause an increase in density. Estrogen alone and tibolone are less likely to cause an increase in density. The sensitivity and specificity of mammography are decreased, with increased risk of interval carcinoma and rate of short interval follow-up from false positive results. The issue with regards to interruption of the hormonal therapy prior to mammography, and the duration of the interruption, are discussed.

摘要

相似文献

1
[Hormones and mammographic breast density].
J Radiol. 2008 Sep;89(9 Pt 2):1196-203. doi: 10.1016/s0221-0363(08)73930-1.
2
Biological significance of interventions that change breast density.
J Natl Cancer Inst. 2003 Jan 1;95(1):4-5. doi: 10.1093/jnci/95.1.4.
3
The need for tissue selective menopausal agents.对组织选择性更年期药物的需求。
Gynecol Endocrinol. 2005 Jul;21 Suppl 1:22-7. doi: 10.1080/09513590400030020.
4
Effects of hormone replacement therapy on mammographic findings.激素替代疗法对乳房X光检查结果的影响。
Arch Gynecol Obstet. 2003 Apr;268(1):5-8. doi: 10.1007/s00404-002-0306-7. Epub 2002 Jun 6.
5
Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.替勃龙与连续联合雌激素加孕激素激素疗法对性激素结合球蛋白和游离睾酮水平的不同影响——与乳房X线密度的关联
Gynecol Endocrinol. 2005 Feb;20(2):110-5. doi: 10.1080/09513590400021151.
6
Postmenopausal hormone therapy and mammographic breast density.绝经后激素治疗与乳腺钼靶密度
Maturitas. 2006 Jan 10;53(1):59-64. doi: 10.1016/j.maturitas.2005.02.010. Epub 2005 Jun 6.
7
[Breast density: a major parameter to follow during hormone replacement therapy].[乳腺密度:激素替代疗法期间需关注的主要参数]
Gynecol Obstet Fertil. 2009 Jul-Aug;37(7-8):657-60. doi: 10.1016/j.gyobfe.2009.04.023. Epub 2009 Jul 3.
8
[Effects of hormonal replacement therapy on breast density in postmenopausal women].[激素替代疗法对绝经后女性乳腺密度的影响]
Minerva Ginecol. 2004 Apr;56(2):125-30.
9
[Menopausal hormonal therapies: impact on mammographic breast density].[更年期激素疗法:对乳腺钼靶密度的影响]
J Radiol. 2004 Oct;85(10 Pt 1):1673-86. doi: 10.1016/s0221-0363(04)97731-1.
10
[Hormone therapy and risk for breast cancer in Finnish postmenopausal women].[芬兰绝经后女性的激素治疗与乳腺癌风险]
Duodecim. 2011;127(3):235-42.

引用本文的文献

1
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.